Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria
暂无分享,去创建一个
M. Karsdal | H. Parving | T. Hansen | P. Rossing | M. Tepel | H. Reinhard | F. Genovese | B. V. von Scholten | D. Rasmussen | P. Jacobsen | S. H. Nielsen | S. Nielsen | Martin Tepel
[1] C. Soeller,et al. Increased collagen within the transverse tubules in human heart failure , 2017, Cardiovascular research.
[2] M. Karsdal,et al. Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease , 2017, PloS one.
[3] A. Vlahou,et al. A urinary proteome‐based classifier for the early detection of decline in glomerular filtration , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] O. Pedersen,et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial , 2016, Diabetologia.
[5] H. Parving,et al. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria , 2016, Diabetologia.
[6] M. Karsdal,et al. Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes , 2016, Diabetologia.
[7] M. Karsdal,et al. Collagen Type III and VI Turnover in Response to Long-Term Immobilization , 2015, PloS one.
[8] P. Bonaldo,et al. Collagen VI at a glance , 2015, Journal of Cell Science.
[9] H. Parving,et al. O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .
[10] M. Karsdal,et al. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[11] J. Coresh,et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.
[12] Desmond E. Williams,et al. Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.
[13] M. Karsdal,et al. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? , 2014, Fibrogenesis & tissue repair.
[14] J. Varga,et al. Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction , 2014, Nature Communications.
[15] Desmond E. Williams,et al. Changes in diabetes-related complications in the United States. , 2014, The New England journal of medicine.
[16] J. Sowers,et al. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system , 2013, Hormone molecular biology and clinical investigation.
[17] M. Joffe,et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[18] D. Weihrauch,et al. Absence of Type VI Collagen Paradoxically Improves Cardiac Function, Structure, and Remodeling After Myocardial Infarction , 2012, Circulation research.
[19] E. Bonora,et al. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. , 2012, American Society of Nephrology. Clinical Journal.
[20] Youhua Liu. Cellular and molecular mechanisms of renal fibrosis , 2011, Nature Reviews Nephrology.
[21] H. Parving,et al. Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[23] Michael J. Pencina,et al. Statistical methods for assessment of added usefulness of new biomarkers , 2010, Clinical chemistry and laboratory medicine.
[24] M. Girolami,et al. Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease* , 2010, Molecular & Cellular Proteomics.
[25] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[26] O. Pedersen,et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.
[27] H. Folkesson,et al. Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. , 2006, American journal of physiology. Heart and circulatory physiology.
[28] G. Magro,et al. Immunohistochemical distribution of type VI collagen in developing human kidney , 1996, The Histochemical Journal.
[29] Zhongxin Zhang,et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.
[30] W. Hornebeck,et al. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. , 2004, Critical reviews in oncology/hematology.
[31] T. Aigner,et al. Collagens--structure, function, and biosynthesis. , 2003, Advanced drug delivery reviews.
[32] U. Schlötzer-Schrehardt,et al. The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion. , 2002, Biochemical and biophysical research communications.
[33] S. Yusuf,et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.
[34] M. Endoh,et al. Analysis of prognostic predictors in idiopathic membranous nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] R. Klein,et al. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. , 2000, Archives of internal medicine.
[36] M. Harris,et al. Diabetes and decline in heart disease mortality in US adults. , 1999, JAMA.
[37] K. Marder,et al. Circulating type VI collagen and undulin, in patients with kidney diseases, after kidney transplantation and on hemodialysis. , 1995, Clinical nephrology.
[38] R. Timpl,et al. Immunohistochemical localization of collagen VI in diabetic glomeruli. , 1994, Kidney international.
[39] T. Crowley,et al. Myocardial glycoproteins in diabetes: type VI collagen is a major PAS-reactive extracellular matrix protein. , 1992, Journal of molecular and cellular cardiology.
[40] D. Schuppan,et al. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease , 1992, Hepatology.
[41] Y Okada,et al. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[42] H. D. de Wardener,et al. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. , 1968, Lancet.